Retinal Dystrophy Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Peripheral Dystrophy, Central Dystrophy); Therapy (Magnetic Therapy, Gene Therapy); Treatment (Drugs, Surgery); Route of administration (Oral, Topical, Other); Distribution channels (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies),Impact of covid-19 pandemic.
Report Code: TIPRE00015288 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Retinal Dystrophy Treatment Market - By Type
1.3.2 Retinal Dystrophy Treatment Market - By Therapy
1.3.3 Retinal Dystrophy Treatment Market - By Treatment
1.3.4 Retinal Dystrophy Treatment Market - By Route of administration
1.3.5 Retinal Dystrophy Treatment Market - By Distribution channels
1.3.6 Retinal Dystrophy Treatment Market - By Region
1.3.6.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. RETINAL DYSTROPHY TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. RETINAL DYSTROPHY TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. RETINAL DYSTROPHY TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. RETINAL DYSTROPHY TREATMENT - GLOBAL MARKET OVERVIEW
6.2. RETINAL DYSTROPHY TREATMENT - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. RETINAL DYSTROPHY TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 – TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. PERIPHERAL DYSTROPHY
7.3.1. Overview
7.3.2. Peripheral Dystrophy Market Forecast and Analysis
7.4. CENTRAL DYSTROPHY
7.4.1. Overview
7.4.2. Central Dystrophy Market Forecast and Analysis
8. RETINAL DYSTROPHY TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 – THERAPY
8.1. OVERVIEW
8.2. THERAPY MARKET FORECASTS AND ANALYSIS
8.3. MAGNETIC THERAPY
8.3.1. Overview
8.3.2. Magnetic Therapy Market Forecast and Analysis
8.4. GENE THERAPY
8.4.1. Overview
8.4.2. Gene Therapy Market Forecast and Analysis
9. RETINAL DYSTROPHY TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 – TREATMENT
9.1. OVERVIEW
9.2. TREATMENT MARKET FORECASTS AND ANALYSIS
9.3. DRUGS
9.3.1. Overview
9.3.2. Drugs Market Forecast and Analysis
9.4. SURGERY
9.4.1. Overview
9.4.2. Surgery Market Forecast and Analysis
10. RETINAL DYSTROPHY TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 – ROUTE OF ADMINISTRATION
10.1. OVERVIEW
10.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
10.3. ORAL
10.3.1. Overview
10.3.2. Oral Market Forecast and Analysis
10.4. TOPICAL
10.4.1. Overview
10.4.2. Topical Market Forecast and Analysis
10.5. OTHER
10.5.1. Overview
10.5.2. Other Market Forecast and Analysis
11. RETINAL DYSTROPHY TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 – DISTRIBUTION CHANNELS
11.1. OVERVIEW
11.2. DISTRIBUTION CHANNELS MARKET FORECASTS AND ANALYSIS
11.3. HOSPITAL PHARMACIES
11.3.1. Overview
11.3.2. Hospital Pharmacies Market Forecast and Analysis
11.4. RETAIL PHARMACIES
11.4.1. Overview
11.4.2. Retail Pharmacies Market Forecast and Analysis
11.5. ONLINE PHARMACIES
11.5.1. Overview
11.5.2. Online Pharmacies Market Forecast and Analysis
12. RETINAL DYSTROPHY TREATMENT MARKET REVENUE AND FORECASTS TO 2028 – GEOGRAPHICAL ANALYSIS
12.1. NORTH AMERICA
12.1.1 North America Retinal Dystrophy Treatment Market Overview
12.1.2 North America Retinal Dystrophy Treatment Market Forecasts and Analysis
12.1.3 North America Retinal Dystrophy Treatment Market Forecasts and Analysis - By Type
12.1.4 North America Retinal Dystrophy Treatment Market Forecasts and Analysis - By Therapy
12.1.5 North America Retinal Dystrophy Treatment Market Forecasts and Analysis - By Treatment
12.1.6 North America Retinal Dystrophy Treatment Market Forecasts and Analysis - By Route of administration
12.1.7 North America Retinal Dystrophy Treatment Market Forecasts and Analysis - By Distribution channels
12.1.8 North America Retinal Dystrophy Treatment Market Forecasts and Analysis - By Countries
12.1.8.1 United States Retinal Dystrophy Treatment Market
12.1.8.1.1 United States Retinal Dystrophy Treatment Market by Type
12.1.8.1.2 United States Retinal Dystrophy Treatment Market by Therapy
12.1.8.1.3 United States Retinal Dystrophy Treatment Market by Treatment
12.1.8.1.4 United States Retinal Dystrophy Treatment Market by Route of administration
12.1.8.1.5 United States Retinal Dystrophy Treatment Market by Distribution channels
12.1.8.2 Canada Retinal Dystrophy Treatment Market
12.1.8.2.1 Canada Retinal Dystrophy Treatment Market by Type
12.1.8.2.2 Canada Retinal Dystrophy Treatment Market by Therapy
12.1.8.2.3 Canada Retinal Dystrophy Treatment Market by Treatment
12.1.8.2.4 Canada Retinal Dystrophy Treatment Market by Route of administration
12.1.8.2.5 Canada Retinal Dystrophy Treatment Market by Distribution channels
12.1.8.3 Mexico Retinal Dystrophy Treatment Market
12.1.8.3.1 Mexico Retinal Dystrophy Treatment Market by Type
12.1.8.3.2 Mexico Retinal Dystrophy Treatment Market by Therapy
12.1.8.3.3 Mexico Retinal Dystrophy Treatment Market by Treatment
12.1.8.3.4 Mexico Retinal Dystrophy Treatment Market by Route of administration
12.1.8.3.5 Mexico Retinal Dystrophy Treatment Market by Distribution channels
12.2. EUROPE
12.2.1 Europe Retinal Dystrophy Treatment Market Overview
12.2.2 Europe Retinal Dystrophy Treatment Market Forecasts and Analysis
12.2.3 Europe Retinal Dystrophy Treatment Market Forecasts and Analysis - By Type
12.2.4 Europe Retinal Dystrophy Treatment Market Forecasts and Analysis - By Therapy
12.2.5 Europe Retinal Dystrophy Treatment Market Forecasts and Analysis - By Treatment
12.2.6 Europe Retinal Dystrophy Treatment Market Forecasts and Analysis - By Route of administration
12.2.7 Europe Retinal Dystrophy Treatment Market Forecasts and Analysis - By Distribution channels
12.2.8 Europe Retinal Dystrophy Treatment Market Forecasts and Analysis - By Countries
12.2.8.1 Germany Retinal Dystrophy Treatment Market
12.2.8.1.1 Germany Retinal Dystrophy Treatment Market by Type
12.2.8.1.2 Germany Retinal Dystrophy Treatment Market by Therapy
12.2.8.1.3 Germany Retinal Dystrophy Treatment Market by Treatment
12.2.8.1.4 Germany Retinal Dystrophy Treatment Market by Route of administration
12.2.8.1.5 Germany Retinal Dystrophy Treatment Market by Distribution channels
12.2.8.2 France Retinal Dystrophy Treatment Market
12.2.8.2.1 France Retinal Dystrophy Treatment Market by Type
12.2.8.2.2 France Retinal Dystrophy Treatment Market by Therapy
12.2.8.2.3 France Retinal Dystrophy Treatment Market by Treatment
12.2.8.2.4 France Retinal Dystrophy Treatment Market by Route of administration
12.2.8.2.5 France Retinal Dystrophy Treatment Market by Distribution channels
12.2.8.3 Italy Retinal Dystrophy Treatment Market
12.2.8.3.1 Italy Retinal Dystrophy Treatment Market by Type
12.2.8.3.2 Italy Retinal Dystrophy Treatment Market by Therapy
12.2.8.3.3 Italy Retinal Dystrophy Treatment Market by Treatment
12.2.8.3.4 Italy Retinal Dystrophy Treatment Market by Route of administration
12.2.8.3.5 Italy Retinal Dystrophy Treatment Market by Distribution channels
12.2.8.4 Spain Retinal Dystrophy Treatment Market
12.2.8.4.1 Spain Retinal Dystrophy Treatment Market by Type
12.2.8.4.2 Spain Retinal Dystrophy Treatment Market by Therapy
12.2.8.4.3 Spain Retinal Dystrophy Treatment Market by Treatment
12.2.8.4.4 Spain Retinal Dystrophy Treatment Market by Route of administration
12.2.8.4.5 Spain Retinal Dystrophy Treatment Market by Distribution channels
12.2.8.5 United Kingdom Retinal Dystrophy Treatment Market
12.2.8.5.1 United Kingdom Retinal Dystrophy Treatment Market by Type
12.2.8.5.2 United Kingdom Retinal Dystrophy Treatment Market by Therapy
12.2.8.5.3 United Kingdom Retinal Dystrophy Treatment Market by Treatment
12.2.8.5.4 United Kingdom Retinal Dystrophy Treatment Market by Route of administration
12.2.8.5.5 United Kingdom Retinal Dystrophy Treatment Market by Distribution channels
12.2.8.6 Rest of Europe Retinal Dystrophy Treatment Market
12.2.8.6.1 Rest of Europe Retinal Dystrophy Treatment Market by Type
12.2.8.6.2 Rest of Europe Retinal Dystrophy Treatment Market by Therapy
12.2.8.6.3 Rest of Europe Retinal Dystrophy Treatment Market by Treatment
12.2.8.6.4 Rest of Europe Retinal Dystrophy Treatment Market by Route of administration
12.2.8.6.5 Rest of Europe Retinal Dystrophy Treatment Market by Distribution channels
12.3. ASIA-PACIFIC
12.3.1 Asia-Pacific Retinal Dystrophy Treatment Market Overview
12.3.2 Asia-Pacific Retinal Dystrophy Treatment Market Forecasts and Analysis
12.3.3 Asia-Pacific Retinal Dystrophy Treatment Market Forecasts and Analysis - By Type
12.3.4 Asia-Pacific Retinal Dystrophy Treatment Market Forecasts and Analysis - By Therapy
12.3.5 Asia-Pacific Retinal Dystrophy Treatment Market Forecasts and Analysis - By Treatment
12.3.6 Asia-Pacific Retinal Dystrophy Treatment Market Forecasts and Analysis - By Route of administration
12.3.7 Asia-Pacific Retinal Dystrophy Treatment Market Forecasts and Analysis - By Distribution channels
12.3.8 Asia-Pacific Retinal Dystrophy Treatment Market Forecasts and Analysis - By Countries
12.3.8.1 Australia Retinal Dystrophy Treatment Market
12.3.8.1.1 Australia Retinal Dystrophy Treatment Market by Type
12.3.8.1.2 Australia Retinal Dystrophy Treatment Market by Therapy
12.3.8.1.3 Australia Retinal Dystrophy Treatment Market by Treatment
12.3.8.1.4 Australia Retinal Dystrophy Treatment Market by Route of administration
12.3.8.1.5 Australia Retinal Dystrophy Treatment Market by Distribution channels
12.3.8.2 China Retinal Dystrophy Treatment Market
12.3.8.2.1 China Retinal Dystrophy Treatment Market by Type
12.3.8.2.2 China Retinal Dystrophy Treatment Market by Therapy
12.3.8.2.3 China Retinal Dystrophy Treatment Market by Treatment
12.3.8.2.4 China Retinal Dystrophy Treatment Market by Route of administration
12.3.8.2.5 China Retinal Dystrophy Treatment Market by Distribution channels
12.3.8.3 India Retinal Dystrophy Treatment Market
12.3.8.3.1 India Retinal Dystrophy Treatment Market by Type
12.3.8.3.2 India Retinal Dystrophy Treatment Market by Therapy
12.3.8.3.3 India Retinal Dystrophy Treatment Market by Treatment
12.3.8.3.4 India Retinal Dystrophy Treatment Market by Route of administration
12.3.8.3.5 India Retinal Dystrophy Treatment Market by Distribution channels
12.3.8.4 Japan Retinal Dystrophy Treatment Market
12.3.8.4.1 Japan Retinal Dystrophy Treatment Market by Type
12.3.8.4.2 Japan Retinal Dystrophy Treatment Market by Therapy
12.3.8.4.3 Japan Retinal Dystrophy Treatment Market by Treatment
12.3.8.4.4 Japan Retinal Dystrophy Treatment Market by Route of administration
12.3.8.4.5 Japan Retinal Dystrophy Treatment Market by Distribution channels
12.3.8.5 South Korea Retinal Dystrophy Treatment Market
12.3.8.5.1 South Korea Retinal Dystrophy Treatment Market by Type
12.3.8.5.2 South Korea Retinal Dystrophy Treatment Market by Therapy
12.3.8.5.3 South Korea Retinal Dystrophy Treatment Market by Treatment
12.3.8.5.4 South Korea Retinal Dystrophy Treatment Market by Route of administration
12.3.8.5.5 South Korea Retinal Dystrophy Treatment Market by Distribution channels
12.3.8.6 Rest of Asia-Pacific Retinal Dystrophy Treatment Market
12.3.8.6.1 Rest of Asia-Pacific Retinal Dystrophy Treatment Market by Type
12.3.8.6.2 Rest of Asia-Pacific Retinal Dystrophy Treatment Market by Therapy
12.3.8.6.3 Rest of Asia-Pacific Retinal Dystrophy Treatment Market by Treatment
12.3.8.6.4 Rest of Asia-Pacific Retinal Dystrophy Treatment Market by Route of administration
12.3.8.6.5 Rest of Asia-Pacific Retinal Dystrophy Treatment Market by Distribution channels
12.4. MIDDLE EAST AND AFRICA
12.4.1 Middle East and Africa Retinal Dystrophy Treatment Market Overview
12.4.2 Middle East and Africa Retinal Dystrophy Treatment Market Forecasts and Analysis
12.4.3 Middle East and Africa Retinal Dystrophy Treatment Market Forecasts and Analysis - By Type
12.4.4 Middle East and Africa Retinal Dystrophy Treatment Market Forecasts and Analysis - By Therapy
12.4.5 Middle East and Africa Retinal Dystrophy Treatment Market Forecasts and Analysis - By Treatment
12.4.6 Middle East and Africa Retinal Dystrophy Treatment Market Forecasts and Analysis - By Route of administration
12.4.7 Middle East and Africa Retinal Dystrophy Treatment Market Forecasts and Analysis - By Distribution channels
12.4.8 Middle East and Africa Retinal Dystrophy Treatment Market Forecasts and Analysis - By Countries
12.4.8.1 South Africa Retinal Dystrophy Treatment Market
12.4.8.1.1 South Africa Retinal Dystrophy Treatment Market by Type
12.4.8.1.2 South Africa Retinal Dystrophy Treatment Market by Therapy
12.4.8.1.3 South Africa Retinal Dystrophy Treatment Market by Treatment
12.4.8.1.4 South Africa Retinal Dystrophy Treatment Market by Route of administration
12.4.8.1.5 South Africa Retinal Dystrophy Treatment Market by Distribution channels
12.4.8.2 Saudi Arabia Retinal Dystrophy Treatment Market
12.4.8.2.1 Saudi Arabia Retinal Dystrophy Treatment Market by Type
12.4.8.2.2 Saudi Arabia Retinal Dystrophy Treatment Market by Therapy
12.4.8.2.3 Saudi Arabia Retinal Dystrophy Treatment Market by Treatment
12.4.8.2.4 Saudi Arabia Retinal Dystrophy Treatment Market by Route of administration
12.4.8.2.5 Saudi Arabia Retinal Dystrophy Treatment Market by Distribution channels
12.4.8.3 U.A.E Retinal Dystrophy Treatment Market
12.4.8.3.1 U.A.E Retinal Dystrophy Treatment Market by Type
12.4.8.3.2 U.A.E Retinal Dystrophy Treatment Market by Therapy
12.4.8.3.3 U.A.E Retinal Dystrophy Treatment Market by Treatment
12.4.8.3.4 U.A.E Retinal Dystrophy Treatment Market by Route of administration
12.4.8.3.5 U.A.E Retinal Dystrophy Treatment Market by Distribution channels
12.4.8.4 Rest of Middle East and Africa Retinal Dystrophy Treatment Market
12.4.8.4.1 Rest of Middle East and Africa Retinal Dystrophy Treatment Market by Type
12.4.8.4.2 Rest of Middle East and Africa Retinal Dystrophy Treatment Market by Therapy
12.4.8.4.3 Rest of Middle East and Africa Retinal Dystrophy Treatment Market by Treatment
12.4.8.4.4 Rest of Middle East and Africa Retinal Dystrophy Treatment Market by Route of administration
12.4.8.4.5 Rest of Middle East and Africa Retinal Dystrophy Treatment Market by Distribution channels
12.5. SOUTH AND CENTRAL AMERICA
12.5.1 South and Central America Retinal Dystrophy Treatment Market Overview
12.5.2 South and Central America Retinal Dystrophy Treatment Market Forecasts and Analysis
12.5.3 South and Central America Retinal Dystrophy Treatment Market Forecasts and Analysis - By Type
12.5.4 South and Central America Retinal Dystrophy Treatment Market Forecasts and Analysis - By Therapy
12.5.5 South and Central America Retinal Dystrophy Treatment Market Forecasts and Analysis - By Treatment
12.5.6 South and Central America Retinal Dystrophy Treatment Market Forecasts and Analysis - By Route of administration
12.5.7 South and Central America Retinal Dystrophy Treatment Market Forecasts and Analysis - By Distribution channels
12.5.8 South and Central America Retinal Dystrophy Treatment Market Forecasts and Analysis - By Countries
12.5.8.1 Brazil Retinal Dystrophy Treatment Market
12.5.8.1.1 Brazil Retinal Dystrophy Treatment Market by Type
12.5.8.1.2 Brazil Retinal Dystrophy Treatment Market by Therapy
12.5.8.1.3 Brazil Retinal Dystrophy Treatment Market by Treatment
12.5.8.1.4 Brazil Retinal Dystrophy Treatment Market by Route of administration
12.5.8.1.5 Brazil Retinal Dystrophy Treatment Market by Distribution channels
12.5.8.2 Argentina Retinal Dystrophy Treatment Market
12.5.8.2.1 Argentina Retinal Dystrophy Treatment Market by Type
12.5.8.2.2 Argentina Retinal Dystrophy Treatment Market by Therapy
12.5.8.2.3 Argentina Retinal Dystrophy Treatment Market by Treatment
12.5.8.2.4 Argentina Retinal Dystrophy Treatment Market by Route of administration
12.5.8.2.5 Argentina Retinal Dystrophy Treatment Market by Distribution channels
12.5.8.3 Rest of South and Central America Retinal Dystrophy Treatment Market
12.5.8.3.1 Rest of South and Central America Retinal Dystrophy Treatment Market by Type
12.5.8.3.2 Rest of South and Central America Retinal Dystrophy Treatment Market by Therapy
12.5.8.3.3 Rest of South and Central America Retinal Dystrophy Treatment Market by Treatment
12.5.8.3.4 Rest of South and Central America Retinal Dystrophy Treatment Market by Route of administration
12.5.8.3.5 Rest of South and Central America Retinal Dystrophy Treatment Market by Distribution channels
13. IMPACT OF COVID-19 PANDEMIC ON GLOBAL RETINAL DYSTROPHY TREATMENT MARKET
13.1 North America
13.2 Europe
13.3 Asia-Pacific
13.4 Rest of the World
14. INDUSTRY LANDSCAPE
14.1. MERGERS AND ACQUISITIONS
14.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
14.3. NEW PRODUCT LAUNCHES
14.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
15. RETINAL DYSTROPHY TREATMENT MARKET, KEY COMPANY PROFILES
15.1. SPARK THERAPEUTICS, INC.
15.1.1. Key Facts
15.1.2. Business Description
15.1.3. Products and Services
15.1.4. Financial Overview
15.1.5. SWOT Analysis
15.1.6. Key Developments
15.2. NOVARTIS AG
15.2.1. Key Facts
15.2.2. Business Description
15.2.3. Products and Services
15.2.4. Financial Overview
15.2.5. SWOT Analysis
15.2.6. Key Developments
15.3. BIOGEN
15.3.1. Key Facts
15.3.2. Business Description
15.3.3. Products and Services
15.3.4. Financial Overview
15.3.5. SWOT Analysis
15.3.6. Key Developments
15.4. HORAMA S.A.
15.4.1. Key Facts
15.4.2. Business Description
15.4.3. Products and Services
15.4.4. Financial Overview
15.4.5. SWOT Analysis
15.4.6. Key Developments
15.5. MEIRAGTX LIMITED
15.5.1. Key Facts
15.5.2. Business Description
15.5.3. Products and Services
15.5.4. Financial Overview
15.5.5. SWOT Analysis
15.5.6. Key Developments
15.6. RENEURON GROUP PLC.
15.6.1. Key Facts
15.6.2. Business Description
15.6.3. Products and Services
15.6.4. Financial Overview
15.6.5. SWOT Analysis
15.6.6. Key Developments
15.7. RETINAGENIX, LLC.
15.7.1. Key Facts
15.7.2. Business Description
15.7.3. Products and Services
15.7.4. Financial Overview
15.7.5. SWOT Analysis
15.7.6. Key Developments
15.8. NOVELION THERAPEUTICS INC.
15.8.1. Key Facts
15.8.2. Business Description
15.8.3. Products and Services
15.8.4. Financial Overview
15.8.5. SWOT Analysis
15.8.6. Key Developments
15.9. IVERIC BIO.
15.9.1. Key Facts
15.9.2. Business Description
15.9.3. Products and Services
15.9.4. Financial Overview
15.9.5. SWOT Analysis
15.9.6. Key Developments
15.10. REFLECTION BIOTECHNOLOGIES
15.10.1. Key Facts
15.10.2. Business Description
15.10.3. Products and Services
15.10.4. Financial Overview
15.10.5. SWOT Analysis
15.10.6. Key Developments
16. APPENDIX
16.1. ABOUT THE INSIGHT PARTNERS
16.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Retinal Dystrophy Treatment Market - By Type
1.3.2 Retinal Dystrophy Treatment Market - By Therapy
1.3.3 Retinal Dystrophy Treatment Market - By Treatment
1.3.4 Retinal Dystrophy Treatment Market - By Route of administration
1.3.5 Retinal Dystrophy Treatment Market - By Distribution channels
1.3.6 Retinal Dystrophy Treatment Market - By Region
1.3.6.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. RETINAL DYSTROPHY TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. RETINAL DYSTROPHY TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. RETINAL DYSTROPHY TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. RETINAL DYSTROPHY TREATMENT - GLOBAL MARKET OVERVIEW
6.2. RETINAL DYSTROPHY TREATMENT - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. RETINAL DYSTROPHY TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 – TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. PERIPHERAL DYSTROPHY
7.3.1. Overview
7.3.2. Peripheral Dystrophy Market Forecast and Analysis
7.4. CENTRAL DYSTROPHY
7.4.1. Overview
7.4.2. Central Dystrophy Market Forecast and Analysis
8. RETINAL DYSTROPHY TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 – THERAPY
8.1. OVERVIEW
8.2. THERAPY MARKET FORECASTS AND ANALYSIS
8.3. MAGNETIC THERAPY
8.3.1. Overview
8.3.2. Magnetic Therapy Market Forecast and Analysis
8.4. GENE THERAPY
8.4.1. Overview
8.4.2. Gene Therapy Market Forecast and Analysis
9. RETINAL DYSTROPHY TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 – TREATMENT
9.1. OVERVIEW
9.2. TREATMENT MARKET FORECASTS AND ANALYSIS
9.3. DRUGS
9.3.1. Overview
9.3.2. Drugs Market Forecast and Analysis
9.4. SURGERY
9.4.1. Overview
9.4.2. Surgery Market Forecast and Analysis
10. RETINAL DYSTROPHY TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 – ROUTE OF ADMINISTRATION
10.1. OVERVIEW
10.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
10.3. ORAL
10.3.1. Overview
10.3.2. Oral Market Forecast and Analysis
10.4. TOPICAL
10.4.1. Overview
10.4.2. Topical Market Forecast and Analysis
10.5. OTHER
10.5.1. Overview
10.5.2. Other Market Forecast and Analysis
11. RETINAL DYSTROPHY TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 – DISTRIBUTION CHANNELS
11.1. OVERVIEW
11.2. DISTRIBUTION CHANNELS MARKET FORECASTS AND ANALYSIS
11.3. HOSPITAL PHARMACIES
11.3.1. Overview
11.3.2. Hospital Pharmacies Market Forecast and Analysis
11.4. RETAIL PHARMACIES
11.4.1. Overview
11.4.2. Retail Pharmacies Market Forecast and Analysis
11.5. ONLINE PHARMACIES
11.5.1. Overview
11.5.2. Online Pharmacies Market Forecast and Analysis
12. RETINAL DYSTROPHY TREATMENT MARKET REVENUE AND FORECASTS TO 2028 – GEOGRAPHICAL ANALYSIS
12.1. NORTH AMERICA
12.1.1 North America Retinal Dystrophy Treatment Market Overview
12.1.2 North America Retinal Dystrophy Treatment Market Forecasts and Analysis
12.1.3 North America Retinal Dystrophy Treatment Market Forecasts and Analysis - By Type
12.1.4 North America Retinal Dystrophy Treatment Market Forecasts and Analysis - By Therapy
12.1.5 North America Retinal Dystrophy Treatment Market Forecasts and Analysis - By Treatment
12.1.6 North America Retinal Dystrophy Treatment Market Forecasts and Analysis - By Route of administration
12.1.7 North America Retinal Dystrophy Treatment Market Forecasts and Analysis - By Distribution channels
12.1.8 North America Retinal Dystrophy Treatment Market Forecasts and Analysis - By Countries
12.1.8.1 United States Retinal Dystrophy Treatment Market
12.1.8.1.1 United States Retinal Dystrophy Treatment Market by Type
12.1.8.1.2 United States Retinal Dystrophy Treatment Market by Therapy
12.1.8.1.3 United States Retinal Dystrophy Treatment Market by Treatment
12.1.8.1.4 United States Retinal Dystrophy Treatment Market by Route of administration
12.1.8.1.5 United States Retinal Dystrophy Treatment Market by Distribution channels
12.1.8.2 Canada Retinal Dystrophy Treatment Market
12.1.8.2.1 Canada Retinal Dystrophy Treatment Market by Type
12.1.8.2.2 Canada Retinal Dystrophy Treatment Market by Therapy
12.1.8.2.3 Canada Retinal Dystrophy Treatment Market by Treatment
12.1.8.2.4 Canada Retinal Dystrophy Treatment Market by Route of administration
12.1.8.2.5 Canada Retinal Dystrophy Treatment Market by Distribution channels
12.1.8.3 Mexico Retinal Dystrophy Treatment Market
12.1.8.3.1 Mexico Retinal Dystrophy Treatment Market by Type
12.1.8.3.2 Mexico Retinal Dystrophy Treatment Market by Therapy
12.1.8.3.3 Mexico Retinal Dystrophy Treatment Market by Treatment
12.1.8.3.4 Mexico Retinal Dystrophy Treatment Market by Route of administration
12.1.8.3.5 Mexico Retinal Dystrophy Treatment Market by Distribution channels
12.2. EUROPE
12.2.1 Europe Retinal Dystrophy Treatment Market Overview
12.2.2 Europe Retinal Dystrophy Treatment Market Forecasts and Analysis
12.2.3 Europe Retinal Dystrophy Treatment Market Forecasts and Analysis - By Type
12.2.4 Europe Retinal Dystrophy Treatment Market Forecasts and Analysis - By Therapy
12.2.5 Europe Retinal Dystrophy Treatment Market Forecasts and Analysis - By Treatment
12.2.6 Europe Retinal Dystrophy Treatment Market Forecasts and Analysis - By Route of administration
12.2.7 Europe Retinal Dystrophy Treatment Market Forecasts and Analysis - By Distribution channels
12.2.8 Europe Retinal Dystrophy Treatment Market Forecasts and Analysis - By Countries
12.2.8.1 Germany Retinal Dystrophy Treatment Market
12.2.8.1.1 Germany Retinal Dystrophy Treatment Market by Type
12.2.8.1.2 Germany Retinal Dystrophy Treatment Market by Therapy
12.2.8.1.3 Germany Retinal Dystrophy Treatment Market by Treatment
12.2.8.1.4 Germany Retinal Dystrophy Treatment Market by Route of administration
12.2.8.1.5 Germany Retinal Dystrophy Treatment Market by Distribution channels
12.2.8.2 France Retinal Dystrophy Treatment Market
12.2.8.2.1 France Retinal Dystrophy Treatment Market by Type
12.2.8.2.2 France Retinal Dystrophy Treatment Market by Therapy
12.2.8.2.3 France Retinal Dystrophy Treatment Market by Treatment
12.2.8.2.4 France Retinal Dystrophy Treatment Market by Route of administration
12.2.8.2.5 France Retinal Dystrophy Treatment Market by Distribution channels
12.2.8.3 Italy Retinal Dystrophy Treatment Market
12.2.8.3.1 Italy Retinal Dystrophy Treatment Market by Type
12.2.8.3.2 Italy Retinal Dystrophy Treatment Market by Therapy
12.2.8.3.3 Italy Retinal Dystrophy Treatment Market by Treatment
12.2.8.3.4 Italy Retinal Dystrophy Treatment Market by Route of administration
12.2.8.3.5 Italy Retinal Dystrophy Treatment Market by Distribution channels
12.2.8.4 Spain Retinal Dystrophy Treatment Market
12.2.8.4.1 Spain Retinal Dystrophy Treatment Market by Type
12.2.8.4.2 Spain Retinal Dystrophy Treatment Market by Therapy
12.2.8.4.3 Spain Retinal Dystrophy Treatment Market by Treatment
12.2.8.4.4 Spain Retinal Dystrophy Treatment Market by Route of administration
12.2.8.4.5 Spain Retinal Dystrophy Treatment Market by Distribution channels
12.2.8.5 United Kingdom Retinal Dystrophy Treatment Market
12.2.8.5.1 United Kingdom Retinal Dystrophy Treatment Market by Type
12.2.8.5.2 United Kingdom Retinal Dystrophy Treatment Market by Therapy
12.2.8.5.3 United Kingdom Retinal Dystrophy Treatment Market by Treatment
12.2.8.5.4 United Kingdom Retinal Dystrophy Treatment Market by Route of administration
12.2.8.5.5 United Kingdom Retinal Dystrophy Treatment Market by Distribution channels
12.2.8.6 Rest of Europe Retinal Dystrophy Treatment Market
12.2.8.6.1 Rest of Europe Retinal Dystrophy Treatment Market by Type
12.2.8.6.2 Rest of Europe Retinal Dystrophy Treatment Market by Therapy
12.2.8.6.3 Rest of Europe Retinal Dystrophy Treatment Market by Treatment
12.2.8.6.4 Rest of Europe Retinal Dystrophy Treatment Market by Route of administration
12.2.8.6.5 Rest of Europe Retinal Dystrophy Treatment Market by Distribution channels
12.3. ASIA-PACIFIC
12.3.1 Asia-Pacific Retinal Dystrophy Treatment Market Overview
12.3.2 Asia-Pacific Retinal Dystrophy Treatment Market Forecasts and Analysis
12.3.3 Asia-Pacific Retinal Dystrophy Treatment Market Forecasts and Analysis - By Type
12.3.4 Asia-Pacific Retinal Dystrophy Treatment Market Forecasts and Analysis - By Therapy
12.3.5 Asia-Pacific Retinal Dystrophy Treatment Market Forecasts and Analysis - By Treatment
12.3.6 Asia-Pacific Retinal Dystrophy Treatment Market Forecasts and Analysis - By Route of administration
12.3.7 Asia-Pacific Retinal Dystrophy Treatment Market Forecasts and Analysis - By Distribution channels
12.3.8 Asia-Pacific Retinal Dystrophy Treatment Market Forecasts and Analysis - By Countries
12.3.8.1 Australia Retinal Dystrophy Treatment Market
12.3.8.1.1 Australia Retinal Dystrophy Treatment Market by Type
12.3.8.1.2 Australia Retinal Dystrophy Treatment Market by Therapy
12.3.8.1.3 Australia Retinal Dystrophy Treatment Market by Treatment
12.3.8.1.4 Australia Retinal Dystrophy Treatment Market by Route of administration
12.3.8.1.5 Australia Retinal Dystrophy Treatment Market by Distribution channels
12.3.8.2 China Retinal Dystrophy Treatment Market
12.3.8.2.1 China Retinal Dystrophy Treatment Market by Type
12.3.8.2.2 China Retinal Dystrophy Treatment Market by Therapy
12.3.8.2.3 China Retinal Dystrophy Treatment Market by Treatment
12.3.8.2.4 China Retinal Dystrophy Treatment Market by Route of administration
12.3.8.2.5 China Retinal Dystrophy Treatment Market by Distribution channels
12.3.8.3 India Retinal Dystrophy Treatment Market
12.3.8.3.1 India Retinal Dystrophy Treatment Market by Type
12.3.8.3.2 India Retinal Dystrophy Treatment Market by Therapy
12.3.8.3.3 India Retinal Dystrophy Treatment Market by Treatment
12.3.8.3.4 India Retinal Dystrophy Treatment Market by Route of administration
12.3.8.3.5 India Retinal Dystrophy Treatment Market by Distribution channels
12.3.8.4 Japan Retinal Dystrophy Treatment Market
12.3.8.4.1 Japan Retinal Dystrophy Treatment Market by Type
12.3.8.4.2 Japan Retinal Dystrophy Treatment Market by Therapy
12.3.8.4.3 Japan Retinal Dystrophy Treatment Market by Treatment
12.3.8.4.4 Japan Retinal Dystrophy Treatment Market by Route of administration
12.3.8.4.5 Japan Retinal Dystrophy Treatment Market by Distribution channels
12.3.8.5 South Korea Retinal Dystrophy Treatment Market
12.3.8.5.1 South Korea Retinal Dystrophy Treatment Market by Type
12.3.8.5.2 South Korea Retinal Dystrophy Treatment Market by Therapy
12.3.8.5.3 South Korea Retinal Dystrophy Treatment Market by Treatment
12.3.8.5.4 South Korea Retinal Dystrophy Treatment Market by Route of administration
12.3.8.5.5 South Korea Retinal Dystrophy Treatment Market by Distribution channels
12.3.8.6 Rest of Asia-Pacific Retinal Dystrophy Treatment Market
12.3.8.6.1 Rest of Asia-Pacific Retinal Dystrophy Treatment Market by Type
12.3.8.6.2 Rest of Asia-Pacific Retinal Dystrophy Treatment Market by Therapy
12.3.8.6.3 Rest of Asia-Pacific Retinal Dystrophy Treatment Market by Treatment
12.3.8.6.4 Rest of Asia-Pacific Retinal Dystrophy Treatment Market by Route of administration
12.3.8.6.5 Rest of Asia-Pacific Retinal Dystrophy Treatment Market by Distribution channels
12.4. MIDDLE EAST AND AFRICA
12.4.1 Middle East and Africa Retinal Dystrophy Treatment Market Overview
12.4.2 Middle East and Africa Retinal Dystrophy Treatment Market Forecasts and Analysis
12.4.3 Middle East and Africa Retinal Dystrophy Treatment Market Forecasts and Analysis - By Type
12.4.4 Middle East and Africa Retinal Dystrophy Treatment Market Forecasts and Analysis - By Therapy
12.4.5 Middle East and Africa Retinal Dystrophy Treatment Market Forecasts and Analysis - By Treatment
12.4.6 Middle East and Africa Retinal Dystrophy Treatment Market Forecasts and Analysis - By Route of administration
12.4.7 Middle East and Africa Retinal Dystrophy Treatment Market Forecasts and Analysis - By Distribution channels
12.4.8 Middle East and Africa Retinal Dystrophy Treatment Market Forecasts and Analysis - By Countries
12.4.8.1 South Africa Retinal Dystrophy Treatment Market
12.4.8.1.1 South Africa Retinal Dystrophy Treatment Market by Type
12.4.8.1.2 South Africa Retinal Dystrophy Treatment Market by Therapy
12.4.8.1.3 South Africa Retinal Dystrophy Treatment Market by Treatment
12.4.8.1.4 South Africa Retinal Dystrophy Treatment Market by Route of administration
12.4.8.1.5 South Africa Retinal Dystrophy Treatment Market by Distribution channels
12.4.8.2 Saudi Arabia Retinal Dystrophy Treatment Market
12.4.8.2.1 Saudi Arabia Retinal Dystrophy Treatment Market by Type
12.4.8.2.2 Saudi Arabia Retinal Dystrophy Treatment Market by Therapy
12.4.8.2.3 Saudi Arabia Retinal Dystrophy Treatment Market by Treatment
12.4.8.2.4 Saudi Arabia Retinal Dystrophy Treatment Market by Route of administration
12.4.8.2.5 Saudi Arabia Retinal Dystrophy Treatment Market by Distribution channels
12.4.8.3 U.A.E Retinal Dystrophy Treatment Market
12.4.8.3.1 U.A.E Retinal Dystrophy Treatment Market by Type
12.4.8.3.2 U.A.E Retinal Dystrophy Treatment Market by Therapy
12.4.8.3.3 U.A.E Retinal Dystrophy Treatment Market by Treatment
12.4.8.3.4 U.A.E Retinal Dystrophy Treatment Market by Route of administration
12.4.8.3.5 U.A.E Retinal Dystrophy Treatment Market by Distribution channels
12.4.8.4 Rest of Middle East and Africa Retinal Dystrophy Treatment Market
12.4.8.4.1 Rest of Middle East and Africa Retinal Dystrophy Treatment Market by Type
12.4.8.4.2 Rest of Middle East and Africa Retinal Dystrophy Treatment Market by Therapy
12.4.8.4.3 Rest of Middle East and Africa Retinal Dystrophy Treatment Market by Treatment
12.4.8.4.4 Rest of Middle East and Africa Retinal Dystrophy Treatment Market by Route of administration
12.4.8.4.5 Rest of Middle East and Africa Retinal Dystrophy Treatment Market by Distribution channels
12.5. SOUTH AND CENTRAL AMERICA
12.5.1 South and Central America Retinal Dystrophy Treatment Market Overview
12.5.2 South and Central America Retinal Dystrophy Treatment Market Forecasts and Analysis
12.5.3 South and Central America Retinal Dystrophy Treatment Market Forecasts and Analysis - By Type
12.5.4 South and Central America Retinal Dystrophy Treatment Market Forecasts and Analysis - By Therapy
12.5.5 South and Central America Retinal Dystrophy Treatment Market Forecasts and Analysis - By Treatment
12.5.6 South and Central America Retinal Dystrophy Treatment Market Forecasts and Analysis - By Route of administration
12.5.7 South and Central America Retinal Dystrophy Treatment Market Forecasts and Analysis - By Distribution channels
12.5.8 South and Central America Retinal Dystrophy Treatment Market Forecasts and Analysis - By Countries
12.5.8.1 Brazil Retinal Dystrophy Treatment Market
12.5.8.1.1 Brazil Retinal Dystrophy Treatment Market by Type
12.5.8.1.2 Brazil Retinal Dystrophy Treatment Market by Therapy
12.5.8.1.3 Brazil Retinal Dystrophy Treatment Market by Treatment
12.5.8.1.4 Brazil Retinal Dystrophy Treatment Market by Route of administration
12.5.8.1.5 Brazil Retinal Dystrophy Treatment Market by Distribution channels
12.5.8.2 Argentina Retinal Dystrophy Treatment Market
12.5.8.2.1 Argentina Retinal Dystrophy Treatment Market by Type
12.5.8.2.2 Argentina Retinal Dystrophy Treatment Market by Therapy
12.5.8.2.3 Argentina Retinal Dystrophy Treatment Market by Treatment
12.5.8.2.4 Argentina Retinal Dystrophy Treatment Market by Route of administration
12.5.8.2.5 Argentina Retinal Dystrophy Treatment Market by Distribution channels
12.5.8.3 Rest of South and Central America Retinal Dystrophy Treatment Market
12.5.8.3.1 Rest of South and Central America Retinal Dystrophy Treatment Market by Type
12.5.8.3.2 Rest of South and Central America Retinal Dystrophy Treatment Market by Therapy
12.5.8.3.3 Rest of South and Central America Retinal Dystrophy Treatment Market by Treatment
12.5.8.3.4 Rest of South and Central America Retinal Dystrophy Treatment Market by Route of administration
12.5.8.3.5 Rest of South and Central America Retinal Dystrophy Treatment Market by Distribution channels
13. IMPACT OF COVID-19 PANDEMIC ON GLOBAL RETINAL DYSTROPHY TREATMENT MARKET
13.1 North America
13.2 Europe
13.3 Asia-Pacific
13.4 Rest of the World
14. INDUSTRY LANDSCAPE
14.1. MERGERS AND ACQUISITIONS
14.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
14.3. NEW PRODUCT LAUNCHES
14.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
15. RETINAL DYSTROPHY TREATMENT MARKET, KEY COMPANY PROFILES
15.1. SPARK THERAPEUTICS, INC.
15.1.1. Key Facts
15.1.2. Business Description
15.1.3. Products and Services
15.1.4. Financial Overview
15.1.5. SWOT Analysis
15.1.6. Key Developments
15.2. NOVARTIS AG
15.2.1. Key Facts
15.2.2. Business Description
15.2.3. Products and Services
15.2.4. Financial Overview
15.2.5. SWOT Analysis
15.2.6. Key Developments
15.3. BIOGEN
15.3.1. Key Facts
15.3.2. Business Description
15.3.3. Products and Services
15.3.4. Financial Overview
15.3.5. SWOT Analysis
15.3.6. Key Developments
15.4. HORAMA S.A.
15.4.1. Key Facts
15.4.2. Business Description
15.4.3. Products and Services
15.4.4. Financial Overview
15.4.5. SWOT Analysis
15.4.6. Key Developments
15.5. MEIRAGTX LIMITED
15.5.1. Key Facts
15.5.2. Business Description
15.5.3. Products and Services
15.5.4. Financial Overview
15.5.5. SWOT Analysis
15.5.6. Key Developments
15.6. RENEURON GROUP PLC.
15.6.1. Key Facts
15.6.2. Business Description
15.6.3. Products and Services
15.6.4. Financial Overview
15.6.5. SWOT Analysis
15.6.6. Key Developments
15.7. RETINAGENIX, LLC.
15.7.1. Key Facts
15.7.2. Business Description
15.7.3. Products and Services
15.7.4. Financial Overview
15.7.5. SWOT Analysis
15.7.6. Key Developments
15.8. NOVELION THERAPEUTICS INC.
15.8.1. Key Facts
15.8.2. Business Description
15.8.3. Products and Services
15.8.4. Financial Overview
15.8.5. SWOT Analysis
15.8.6. Key Developments
15.9. IVERIC BIO.
15.9.1. Key Facts
15.9.2. Business Description
15.9.3. Products and Services
15.9.4. Financial Overview
15.9.5. SWOT Analysis
15.9.6. Key Developments
15.10. REFLECTION BIOTECHNOLOGIES
15.10.1. Key Facts
15.10.2. Business Description
15.10.3. Products and Services
15.10.4. Financial Overview
15.10.5. SWOT Analysis
15.10.6. Key Developments
16. APPENDIX
16.1. ABOUT THE INSIGHT PARTNERS
16.2. GLOSSARY OF TERMS
The List of Companies
1. Spark Therapeutics, Inc
2. Novartis AG
3. Biogen
4. HORAMA S.A.
5. MeiraGTx Limited
6. ReNeuron Group plc
7. Retinagenix, LLC
8. Novelion Therapeutics Inc.
9. IVERIC bio
10. Reflection Biotechnologies
1. Spark Therapeutics, Inc
2. Novartis AG
3. Biogen
4. HORAMA S.A.
5. MeiraGTx Limited
6. ReNeuron Group plc
7. Retinagenix, LLC
8. Novelion Therapeutics Inc.
9. IVERIC bio
10. Reflection Biotechnologies
Get the Latest COVID-19 Analysis on this market
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak To Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount